Skip to main content
Log in

Increases in fibrosis-related gene transcripts in livers of dimethylnitrosamine-intoxicated rats

  • Original Paper
  • Published:
Journal of Biomedical Science

Abstract

Fibrosis-related changes in livers of cirrhotic rats induced by dimethylnitrosamine (DMN) have not yet been fully clarified. The aim of this study was to investigate changes in molecular and biochemical markers in DMN-intoxicated rats. DMN was administered to Sprague-Dawley rats for 2 and 5 weeks to induce different degrees of hepatic fibrosis. Liver tissues were assessed for the degree of fibrosis and gene expression. Histological examination of the liver showed a progressive increase in fibrosis scores (1.33 ± 0.21 and 3.03 ± 0.29, respectively) and expansion of fibrous septa with collagen-staining fibers in rats after 2 and 5 weeks of DMN administration. Hepatic protein contents of α-smooth muscle actin (α-SMA) and total collagen were significantly higher in rats administered DMN for both 2 and 5 weeks compared with those in control rats. Hepatic mRNA expressions of α-SMA, transforming growth factor-β1 (TGF-β1), connective tissue growth factor, tissue inhibitor of metalloproteinase-1, and procollagen I and III were increased in DMN rats after 2 and 5 weeks. Abnormal increases in plasma alanine transaminase (ALT) and aspartate transaminase (AST) levels, plasma and mitochondrial MDA levels, and portal venous pressure were also noted in DMN rats. DMN administration to rats for 2 and 5 weeks induced progressive increases in hepatic fibrosis scores, hepatic mRNA expressions of TGF-β1 and procollagen I and III genes, plasma levels of ALT and AST, and portal venous pressure, as well as progressive decreases in both liver and body weights. Our results suggest that DMN administration in rats induces biochemical and molecular changes related to fibrogenesis in the liver.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ala-Kokko L, Pihlajaniemi T, Myers JC, Kivirikko KI, Savolainen ER. Gene expression of type I, III and IV collagens in hepatic fibrosis induced by dimethylnitrosamine in the rat. Biochem J 244:75–79;1987.

    Google Scholar 

  2. Bissell DM, Roulot D, George J. Transforming growth factor β and the liver. Hepatology 34:859–867;2001.

    Google Scholar 

  3. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 342:1350–1358;2000.

    Google Scholar 

  4. Buck M, Kim DJ, Houglum K, Hassanein T, Chojkier M. c-Myb modulates transcription of the alpha-smooth muscle actin gene in activated hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 278:G321-G328;2000.

    Google Scholar 

  5. Castilla A, Prieto J, Fausto N. Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. N Engl J Med 324:933–940;1991.

    Google Scholar 

  6. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159;1987.

    Google Scholar 

  7. Colombato LA, Robin M, Pomier-Layrargues G, Huet P-M. Animal models of portal hypertension. In: Holstege A, Scholmerich J, Hahn E.G., eds. Portal Hypertension. Dordrecht, Kluwer Academic Publishers, 3–14;1995.

    Google Scholar 

  8. De Bleser PJ, Xu G, Rombouts K, Rogiers V, Geerts A. Glutathione levels discriminate between oxidative stress and transforming growth factor-beta signaling in activated rat hepatic stellate cells. J Biol Chem 274:33881–33887;1999.

    Google Scholar 

  9. Duncan MR, Frazier KS, Abramson S, Williams S, Klapper H, Huang X, Grotendorst GR. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by cAMP. FASEB J 13:1774–1786;1999.

    Google Scholar 

  10. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275:2247–2250;2000.

    Google Scholar 

  11. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 38:S38-S53;2003.

    Google Scholar 

  12. Garcia-Trevijano ER, Iraburu MJ, Fontana L, Dominguez-Rosales JA, Auster A, Covarrubias-Pinedo A, Rojkind M. Transforming growth factor beta1 induces the expression of alpha1(I) procollagen mRNA by a hydrogen peroxide-C/EBPbeta-dependent mechanism in rat hepatic stellate cells. Hepatology 29:960–970;1999.

    Google Scholar 

  13. Gebhardt R. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Med 68:289–296;2002.

    Google Scholar 

  14. Groszmann RJ, Loureiro-Silva MR, Tsai M-H. The biology of portal hypertension. In: Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz DA, eds. The Liver: Biology and Pathobiology, ed 4. Philadelphia, Lippincott Williams & Wilkins, 801–830;2001.

    Google Scholar 

  15. Grotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 7:469–480;1996.

    Google Scholar 

  16. Halliwell B, Gutteridge JMC. Free radicals, other reactive species and disease. In: Free Radicals in Biology and Medicine, ed 3. Oxford, Oxford University Press, 617–783;1999.

    Google Scholar 

  17. Hata J, Ikeda E, Uno H, Asano S. Expression of hepatocyte growth factor mRNA in rat liver cirrhosis induced by N-nitrosodimethylamine as evidenced by in situ RT-PCR. J Histochem Cytochem 50:1461–1468;2002.

    Google Scholar 

  18. Hayashi N, Kakimuma T, Soma Y, Grotendorst GR, Tamaki K, Harada M, Igarashi A. Connective tissue growth factor is directly related to liver fibrosis. Hepatogastroenterology 49:133–135;2002.

    Google Scholar 

  19. Hellerbrand C, Stefanovic B, Giordano F, Burchardt ER, Brenner DA. The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo. J Hepatol 30:77–87;1999.

    Google Scholar 

  20. Herbst H, Wege T, Milani S, Pellegrini G, Orzechowski HD, Bechstein WO, Neuhaus P, Gressner AM, Schuppan D. Tissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosis. Am J Pathol 150:1647–1659;1997.

    Google Scholar 

  21. Huang Y-T, Lin H-C, Tsai J-F, Hou M-C, Lee S-D, Hong C-Y. Vascular hyporeactivity persists despite increased contractility after long-term administration of isosorbide dinitrate in portal hypertensive rats. J Hepatol 28:1037–1044;1998.

    Google Scholar 

  22. Huang Y-T, Hsu Y-C, Chen C-J, Liu C-T, Wei Y-H. Oxidative-stress-related changes in the livers of bile-duct-ligated rats. J Biomed Sci 10:170–178;2003.

    Google Scholar 

  23. Jaeschke H, Gores GJ, Cederbaum AI, Hinson JA, Pessayre D, Lemasters JJ. Mechanisms of hepatotoxicity. Toxicol Sci 65:166–176;2002.

    Google Scholar 

  24. Jeong DH, Jang JJ, Lee SJ, Lee JH, Lim IK, Lee MJ, Lee YS. Expression patterns of cell cycle-related proteins in a rat cirrhotic model induced by CCl4 or thioacetamide. J Gastroenterol 36:24–32;2001.

    Google Scholar 

  25. Jezequel AM, Mancini R, Rinaldesi ML, Macarri G, Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 5:174–181;1987.

    Google Scholar 

  26. Kang KW, Choi SH, Ha JR, Kim CW, Kim SG. Inhibition of dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazinyl)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor-beta1 and tumor necrosis factor-alpha expression. Chem Biol Interact 139:61–77;2002.

    Google Scholar 

  27. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 30:48–60;1999.

    Google Scholar 

  28. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct ligation: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 65:305–311;1981.

    Google Scholar 

  29. Lee KS, Buck M, Houglum K, Chojkier M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 96:2461–2468;1995.

    Google Scholar 

  30. Lopez-De Leon A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 33:737–743;1985.

    Google Scholar 

  31. Lu X, Liu P, Liu C, Xu G, Wang X, Chen W, Li F. Role of hepatic sinusoidal endothelium injury in hepatic fibrogenesis induced by dimethylnitrosamine in rats (in Chinese). Zhonghua Gan Zang Bing Za Zhi 10:441–444;2002.

    Google Scholar 

  32. Meagher EA, FitzGerald GA. Indices of lipid peroxidation in vivo: strengths and limitations. Free Radic Biol Med 28:1745–1750;2000.

    Google Scholar 

  33. Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci 114:4359–4369;2001.

    Google Scholar 

  34. Murphy FR, Issa R, Zhou X, Ratnarajah S, Nagase H, Arthur MJ, Benyon C, Iredale JP. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition: implications for reversibility of liver fibrosis. J Biol Chem 277:11069–11076;2002.

    Google Scholar 

  35. Nakamura T, Sakata R, Ueno T, Sata M, Ueno H. Inhibition of transforming growth factor beta prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats. Hepatology 32:247–254;2000.

    Google Scholar 

  36. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology 26:624–633;1997.

    Google Scholar 

  37. Nieto N, Friedman SL, Cederbaum AI. Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived oxygen species. Hepatology 35:62–73;2002.

    Google Scholar 

  38. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358;1979.

    Google Scholar 

  39. Paradis V, Dargere D, Vidaud M, De Gouville AC, Huet S, Martinez V, Gauthier JM, Ba N, Sobesky R, Ratziu V, Bedossa P. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 30:968–976;1999.

    Google Scholar 

  40. Paradis V, Dargere D, Bonvoust F, Vidaud M, Segarini P, Bedossa P. Effects and regulation of connective tissue growth factor on hepatic stellate cells. Lab Invest 82:767–774;2002.

    Google Scholar 

  41. Parola M, Pinzani M, Casini A, Albano E, Poli G, Gentilini A, Gentilini P, Dianzani MU. Stimulation of lipid peroxidation or 4-hydroxy-nonenal treatment increases procollagen alpha 1 (I) gene expression in human liver fat-storing cells. Biochem Biophys Res Commun 194:1044–1050;1993.

    Google Scholar 

  42. Pinzani M, Gentilini P. Biology of hepatic stellate cells and their possible relevance in the pathogenesis of portal hypertension in cirrhosis. Semin Liver Dis 19:397–410;1999.

    Google Scholar 

  43. Poli G. Pathogenesis of liver fibrosis: role of oxidative stress. Mol Aspects Med 21:49–98;2000.

    Google Scholar 

  44. Rojkind M, Greenwel P. Pathophysiology of liver fibrosis. In: Arias IM, Boyer JL, Chisari FV, Fausto N, Schachter D, Shafritz, DA, eds. The Liver: Biology and Pathobiology. ed 4. Philadelphia, Lippincott Williams & Wilkins, 721–738;2001.

    Google Scholar 

  45. Sakaida I, Uchida K, Matsumura Y, Okita K. Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-β1 expression in pig serum-induced rat liver fibrosis. J Hepatol 28:471–479;1998.

    Google Scholar 

  46. Sakaida I, Hironaka K, Terai S, Okita K. Gadolinium chloride reverses dimethylnitrosamine (DMN)-induced rat liver fibrosis with increased matrix metalloproteinases (MMPs) of Kupffer cells. Life Sci 72:943–959;2003.

    Google Scholar 

  47. Sanderson N, Factor V, Nagy P, Kopp J, Kondaiah P, Wakefield L, Roberts AB, Sporn MB, Thorgeirsson SS. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci USA 92:2572–2576;1995.

    Google Scholar 

  48. Scheuer PJ. Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 13:372–374;1991.

    Google Scholar 

  49. Sedlaczek N, Jia JD, Bauer M, Herbst H, Ruehl M, Hahn EG, Schuppan D. Proliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosis. Am J Pathol 158:1239–1244;2001.

    Google Scholar 

  50. Shiba M, Shimizu I, Yasuda M, Ii K, Ito S. Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver 18:196–204;1998.

    Google Scholar 

  51. Svegliati Baroni G, D'Ambrosio L, Ferretti G, Casini A, Di Sario A, Salzano R, Ridolfi F, Saccomanno S, Jezequel AM, Benedetti A. Fibrogenic effect of oxidative stress on rat hepatic stellate cells. Hepatology 27:720–726;1998.

    Google Scholar 

  52. Tada S, Iwamoto H, Nakamuta M, Sugimoto R, Enjoji M, Nakashima Y, Nawata H. A selective ROCK inhibitor, Y27632, prevents dimethylnitrosamine-induced hepatic fibrosis in rats. J Hepatol 34:529–536;2001.

    Google Scholar 

  53. Tahashi Y, Matsuzaki K, Date M, Yoshida K, Furukawa F, Sugano Y, Matsushita M, Himeno Y, Inagaki Y, Inoue K. Differential regulation of TGF-beta signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35:49–61;2002.

    Google Scholar 

  54. Taimr P, Higuchi H, Kocova E, Rippe RA, Friedman SL, Gores GJ. Activated stellate cells express the TRAIL receptor-2/death receptor-5 and undergo TRAIL-mediated apoptosis. Hepatology 37:87–95;2003.

    Google Scholar 

  55. Tsukamoto H, Matsuoka M, French SW. Experimental models of hepatic fibrosis: a review. Semin Liver Dis 10:56–65;1990.

    Google Scholar 

  56. Vendemiale G, Grattagliano I, Caruso ML, Serviddio G, Valentini AM, Pirrelli M, Altomare E. Increased oxidative stress in dimethylnitrosamine-induced liver fibrosis in the rat: effect of N-acetylcysteine and interferon-alpha. Toxicol Appl Pharmacol 175:130–139;2001.

    Google Scholar 

  57. Vercesi A, Reynafarje B, Lehninger AL. Stoichiometry of H+ ejection and Ca2+ uptake coupled to electron transport in rat heart mitochondria. J Biol Chem 253:6379–6385;1978.

    Google Scholar 

  58. Wasser S, Ho JMS, Ang HK, Tan CEL.Salvia miltiorrhiza reduced experimentally-induced hepatic fibrosis in rats. J Hepatol 29:760–771;1998.

    Google Scholar 

  59. Wells RG. Fibrogenesis. V. TGF-beta signaling pathways. Am J Physiol Gastrointest Liver Physiol 279:G845-G850;2000.

    Google Scholar 

  60. Williams EJ, Gaca MDA, Brigstock DR, Arthur MJP, Benyon RC. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells. J Hepatol 32:754–761;2000.

    Google Scholar 

  61. Yoshiji H, Kuriyama S, Miyamoto Y, Thorgeirsson UP, Gomez DE, Kawata M, Yoshii J, Ikenaka Y, Noguchi R, Tsujinoue H, Nakatani T, Thorgeirsson SS, Fukui H. Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model. Hepatology 32:1248–1254;2000.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hsu, YC., Chiu, YT., Lee, CY. et al. Increases in fibrosis-related gene transcripts in livers of dimethylnitrosamine-intoxicated rats. J Biomed Sci 11, 408–417 (2004). https://doi.org/10.1007/BF02254446

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02254446

Key Words

Navigation